Digital Therapeutics Market Outlook:
Digital Therapeutics Market size was valued at USD 8.95 billion in 2025 and is likely to cross USD 48.87 billion by 2035, registering more than 18.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of digital therapeutics is assessed at USD 10.44 billion.
The market is blooming as a result of the slated growth in chronic diseases and related conditions, which are estimated to increase as about 1 out of 3 adults, suffer worldwide from multiple chronic conditions. According to the National Institutes of Health Report 2023, there has been an increase of about 7% from 67% of deaths in 2010 to 74% of deaths in 2019 globally, which are caused by chronic conditions.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of digital therapeutics is assessed at USD 10.44 billion.
The global digital therapeutics market size was valued at over USD 8.95 billion in 2025 and is expected to register a CAGR of more than 18.5%, exceeding USD 48.87 billion revenue by 2035.
North America digital therapeutics market will hold more than 40% share by 2035, driven by the surge in chronic illness and neurology devices, coupled with the geriatric population.
Key players in the market include ResMed, Pear Therapeutics, Inc., Solera Network, Akili Interactive Labs, Inc., Better Therapeutics, LLC, Biofourmis, Click Therapeutics, Inc., Naturalcycles Nordic AB, BehaVR.
